Physician profile
Brent B Setien
NPI 1306130976
$2,303.57
in general payments reported to CMS, 2019-2025
8 companies · $487 in 2025
The $487 reported for 2025 was more than what 90% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $288 · 2021: $453 · 2022: $286 · 2023: $441 · 2024: $119 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984 · Travel and Lodging: $62.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.01 |
| Travel and Lodging | $62.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,283.58 | 2020-2025 | Invisalign, Invisalign First - Comprehensive, Itero Element 5d Plus |
| Patterson Companies, INC. | $366.96 | 2024-2025 | |
| A-Dec, INC. | $251.72 | 2023 | |
| Peter Brasseler Holdings, LLC | $219.00 | 2019 | |
| Straumann USA LLC | $75.00 | 2022 | |
| Dentsply Sirona INC | $55.75 | 2021-2023 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Philips North America LLC | $37.81 | 2019-2023 | |
| Ultradent Products INC | $13.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Setien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.